Stepan Company (NYSE:SCL) Q4 2022 Earnings Call Transcript

David Silver : Good morning. This is kind of a qualitative question. But you did discuss the outlook for 2023 and some detail overall. I was wondering if you could maybe just highlight some thoughts regionally. In other words, of Europe, let’s say, North America and South America, I mean, it would North America, in your opinion. And in your build up to a overall 2023 outlook. Is North America the strongest region, or are there some regional issues that we should kind of keep in mind as we think about the overall 2023 outlook? And of course, I’m thinking maybe geopolitical concerns in Europe or some broader regional issues in Latin America. But how does the regional outlook shakeout in your opinion at this point for 2023?

Scott Behrens: It’s great question, David. And let me take a shot at first talking about kind of destocking and where the underlining demand is. I think everyone’s saw a earlier kind of slowdown in Europe, starting in maybe Q3 last year, whereas in North America, at least in our business, we didn’t see the slowdown, really to start until Q4. So I think Europe’s a little bit ahead in their demand pattern than North America. And I think I said earlier, I think it’s still a little uncertain right now six weeks into the year as to where the North American destocking will end. And a really good demand profile going forward will be able to be established. So I think from that perspective, Europe’s a little bit ahead, but I don’t see any big macro differences between the two regions going forward.

The one watch out is Latin America and the continued high inflation in those emerging economies where the average wage is much lower than in North American Europe, I think they’re going to be more exposed to continue prolonged inflation and could have a better impact or a bigger impact on underlining consumer demand.

David Silver : Thank you very much. That’s a great color, and I appreciate it. My next question would be kind of about new products or and in particular, I think I’ve asked this question some time ago, but does step in track, I guess, there are calculate internally, vitality index, in other words, percentage of revenues from products that have been developed in the last three years, the last five years, something like that? And if not, I was just wondering if you could call out from a revenue or from a margin impact, however, you look at it internally, what are what are the one or two areas with the strongest new sales performance, you know, maybe in 2022. And if we look out another year or two beyond I mean, I’m guessing the functional products areas is at or near the top of the list. But if you could just, you know, highlight some of the advances in your new product sales that would be helpful? Thank you.

Scott Behrens: Yeah. So I first start with, you know, where we are focused on strategic and market growth. And that’s within the agricultural chemicals space as well as specialty alkoxylate. So, you know, in agricultural chemicals €“ we are part of that development pipeline for new active pesticides. And that pipeline is anywhere from five years to 10 years long, for new products to come to market. So we’re deeply embedded in those development pipelines with the large pesticide producers out there, which is a really great place to be and we have new products being launched in multiple regions The other big focus for us is in specialty alkoxylate. You know, we’re talking another double-digit volume growth year in 2022. And we’ve got a team dedicated to continuing to meet customers needs for new and improved technical performance, but also broadening out our product portfolio.